CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Series A Preferred Stock	Preferred Stock	Preferred Stock Series A Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021			0		99,976,253
Beginning balance at Dec. 31, 2021	$ 123,179		$ 0		$ 100	$ 218,762	$ (95,683)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Warrant issuance in conjunction with debt modification	$ 5,764					5,764
Warrant exercise (in shares)	0
Issuance of stock (in shares)				9,566	15,470,148
Issuance of stock	$ 48,417	$ 9,273		$ 9,273	$ 15	48,402
Stock-based compensation expense	1,050					1,050
Preferred stock dividends			$ 531				(531)
Net loss	(65,840)						(65,840)
Ending balance (in shares) at Sep. 30, 2022			9,566		115,446,401
Ending balance at Sep. 30, 2022	121,843		$ 9,804		$ 115	273,978	(162,054)
Beginning balance (in shares) at Jun. 30, 2022			9,566		104,969,199
Beginning balance at Jun. 30, 2022	135,264		$ 9,804		$ 105	253,174	(127,819)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Warrant offerings	5,764					5,764
Issuance of stock (in shares)					10,477,202
Issuance of stock	14,482				$ 10	14,472
Stock-based compensation expense	568					568
Preferred stock dividends	(247)						(247)
Net loss	(33,988)						(33,988)
Ending balance (in shares) at Sep. 30, 2022			9,566		115,446,401
Ending balance at Sep. 30, 2022	121,843		$ 9,804		$ 115	273,978	(162,054)
Beginning balance (in shares) at Dec. 31, 2022			9,566		145,492,971
Beginning balance at Dec. 31, 2022	117,754		$ 9,273		$ 145	294,810	(186,474)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock reacquired in exchange for warrants (in shares)					(12,000,000)
Common stock reacquired in exchange for warrants	(12,491)				$ (12)	(12,479)
Warrant issuance in conjunction with debt modification	16,036					16,036
Warrant offerings	$ 14,991					14,991
Warrant exercise (in shares)	2,740,587				27,258,005
Warrant exercise	$ 3,527				$ 27	3,500
Issuance of stock (in shares)					54,663,601
Issuance of stock	54,134				$ 55	54,079
Common stock issued for share based liabilities due to related party (in shares)					2,460,513
Common stock issued for share based liabilities due to related party	15,000				$ 2	14,998
Convertible promissory notes converted to common stock (in shares)					11,762,956
Convertible promissory notes converted to common stock	4,705				$ 12	4,693
Stock-based compensation expense and issuance of stock (in shares)					3,084,780
Stock-based compensation expense and issuance of stock	$ 4,026				$ 3	4,023
Tax withholdings related to net share settlements of stock-based compensation awards (in shares)	(500,494)				(500,494)
Tax withholdings related to net share settlements of stock-based compensation awards	$ (852)					(852)
Net loss	(62,896)						(62,896)
Ending balance (in shares) at Sep. 30, 2023			9,566		232,222,332
Ending balance at Sep. 30, 2023	153,934		$ 9,273		$ 232	393,799	(249,370)
Beginning balance (in shares) at Jun. 30, 2023			9,566		216,055,887
Beginning balance at Jun. 30, 2023	134,818		$ 9,273		$ 216	355,600	(230,271)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Warrant exercise (in shares)					1,610,184
Warrant exercise	14				$ 1	13
Issuance of stock (in shares)					10,850,699
Issuance of stock	21,786				$ 11	21,775
Common stock issued for share based liabilities due to related party (in shares)					2,460,513
Common stock issued for share based liabilities due to related party	15,000				$ 2	14,998
Stock-based compensation expense and issuance of stock (in shares)					1,245,049
Stock-based compensation expense and issuance of stock	1,415				$ 2	1,413
Net loss	(19,099)						(19,099)
Ending balance (in shares) at Sep. 30, 2023			9,566		232,222,332
Ending balance at Sep. 30, 2023	$ 153,934		$ 9,273		$ 232	$ 393,799	$ (249,370)